Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BDSIW

Biodelivery Sciences International (MM) (BDSIW)

Biodelivery Sciences International (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BDSIW
DateTimeSourceHeadlineSymbolCompany
11/08/20058:44AMBusiness WireBDSI Announces Supply Agreement Relating to BEMA(TM) Fentanyl; Agreement with Aveva Drug Delivery Systems a Key Milestone as BDSNASDAQ:BDSIWBiodelivery Sciences International (MM)
11/01/20056:30AMBusiness WireBDSI Prepares For Phase III with BEMA(TM) Fentanyl Following Positive Results of Comparative Pharmacokinetic StudyNASDAQ:BDSIWBiodelivery Sciences International (MM)
10/05/200510:13AMBusiness WireBDSI Closes Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
09/30/20057:04AMBusiness WireBDSI Prices Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
09/30/20057:00AMBusiness WireBDSI Prices Public Offering of 4.4 Million SharesNASDAQ:BDSIWBiodelivery Sciences International (MM)
09/16/20053:30PMBusiness WireBDSI Announces Director Resignations; Donald Ferguson and Alan Pearce Resign So That Company Can Comply with Nasdaq IndependenceNASDAQ:BDSIWBiodelivery Sciences International (MM)
07/20/20059:28AMBusiness WireBDSI Announces Acceptance of Emezine(R) NDA for Review By FDANASDAQ:BDSIWBiodelivery Sciences International (MM)
07/18/200510:03AMBusiness WireBDSI Secures $7 Million Financing Commitment For Development of BEMA(TM) Fentanyl; Funding Targeted for Phase III Trials of CancNASDAQ:BDSIWBiodelivery Sciences International (MM)
06/03/20056:00AMBusiness WireBDSI Secures Additional $2.5 Million Financing With Laurus Master FundNASDAQ:BDSIWBiodelivery Sciences International (MM)
05/02/20056:30AMBusiness WireBDSI Announces Submission of NDA for Emezine; First Transmucosal Product for the Treatment of Nausea and VomitingNASDAQ:BDSIWBiodelivery Sciences International (MM)
11/12/20043:37PMPR Newswire (US)BDSI Reports Financial Results for the Third Quarter Ended September 30, 2004NASDAQ:BDSIWBiodelivery Sciences International (MM)
04/13/200411:00AMPR Newswire (US)BioDelivery Sciences International, Inc. Announces Licensing of Its Topical BioNasal (TM) Amphotericin B for Chronic SinusitisNASDAQ:BDSIW
04/06/20047:00AMPR Newswire (US)BioDelivery Sciences International, Inc. Reports 2003 ResultsNASDAQ:BDSIWBiodelivery Sciences International (MM)
 Showing the most relevant articles for your search:NASDAQ:BDSIW